Is argatroban a DOAC?
No. Argatroban is not a DOAC (direct oral anticoagulant). It is an injectable direct thrombin inhibitor (a parenteral anticoagulant), typically used in specific situations such as suspected or confirmed heparin-induced thrombocytopenia (HIT).
What kind of anticoagulant is argatroban instead?
Argatroban directly inhibits thrombin (factor IIa). Because it is given as an injection and is not one of the standard oral DOAC drugs (like apixaban, rivaroxaban, dabigatran, or edoxaban), it is categorized separately from DOACs.
How to tell DOACs from argatroban quickly
DOACs are oral, fixed-dose anticoagulants that target a specific coagulation factor (factor Xa or thrombin) and are taken by mouth. Argatroban is injectable and used in contexts where direct thrombin inhibition is needed rather than routine DOAC-style treatment.
Common confusion: “both inhibit thrombin”
Both DOACs and argatroban can inhibit thrombin, but that doesn’t make argatroban a DOAC. “DOAC” is a category defined largely by route (oral) and the specific approved DOAC drugs, not just the mechanism.
Sources
No sources were provided with the question, so I can’t cite specific references here.